AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis in Adolescents.

RecruitingNAAges 12 Years - 14 YearsAllUniversità degli Studi di Ferrara
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate if the adjunctive use of an amine and zinc lactate - containing mouthrinse may give significant benefits in the home-based treatment of plaque-induced gingivitis in adolescents. The study is based on the following hypothesis: the periodontal conditions of participants affected by gingivitis will significantly benefit from the implementation of the self-performed plaque control regimen (consisting of manual toothbrush and amine and zinc lactate toothpaste) with an amine and zinc lactate - containing mouthrinse. The benefit is expected to become manifest in terms of impact on clinical periodontal parameters, ecology of the subgingival environment, patient-reported outcomes and oral-health-related quality of life. In other words, gingivitis participants implementing their self-performed oral hygiene with the investigated mouthrinse are expected

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * systemically healthy; * eligible for oral care provision by Regional Health Service due to low socio-economic status; * at least 16 fully erupted teeth (excluding third molars); * diagnosed with plaque-induced gingivitis (G) or periodontal health (PH) according to the World Workshop case definitions (Trombelli et al. 2018, Chapple et al. 2018); * willing to participate in the study and capable to fully understand and comply with the study procedures (including questionnaire reading and filling). Exclusion Criteria: * pregnant or lactating; * current smoking; * motor and/or cognitive deficit impairing compliance with the study intervals or procedures; * legal guardian not willing to either allow for subject participation in the study or ensure adherence with the study procedures; * teeth with developmental defects (e.g., enamel pearls/projections); * untreated oral lesions, including dental caries or endodontic lesions; * fixed or removable orthodontic appliances or scheduled for orthodontic therapy with a timing not compatible with the experimental phase; * use of antibiotics in the previous 3 months; * use of medications that affect the size of the gingival tissues, such as phenytoin, sodium valproate, certain calcium channel-blocking drugs (e.g., nifedipine, verapamil, diltiazem, amlodipine, felodipine), and immune-regulating drugs (e.g., cyclosporine); * conditions (e.g., Sjögren's syndrome, anxiety, poorly controlled diabetes) or medications (e.g., antihistamines, decongestants, antidepressants) that are associated with hyposalivation.
💊

What it tests

  • toothbrushing
  • flossing
  • Toothpaste Product
  • Mouthrinse
📍

Where

1 site
Operative Unit of Dentistry
Ferrara, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy